Total planned funding: $154,058,686
Allocations
Countries/Regions
India | $154,058,686 |
Organizational Types
Unknown | $75,286,937 |
NGO | $35,950,064 |
Own Agency | $22,125,388 |
University | $8,990,217 |
Private Contractor | $4,098,272 |
Implementing Agency | $3,100,000 |
Multi-lateral Agency | $2,206,808 |
Host Country Government Agency | $1,201,000 |
FBO | $1,100,000 |
Other USG Agency | $0 |
Program Areas
Governance and Systems | $68,520,008 |
Prevention | $33,711,660 |
Management and Operations | $18,004,428 |
Care | $14,946,389 |
Testing | $7,529,402 |
Treatment | $6,919,007 |
Budget Codes
OHSS: Health Systems Strengthening | $42,280,100 |
HVSI: Strategic Information | $21,946,514 |
HVMS: Management and Operations | $18,004,428 |
HVOP: Sexual Prevention: Other Sexual Prevention | $17,473,083 |
HBHC: Care: Adult Care and Support | $9,691,611 |
HVCT: Testing: HIV Testing and Counseling | $7,529,402 |
HTXS: Treatment: Adult Treatment | $6,538,736 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $6,417,476 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $5,328,481 |
HLAB: Laboratory Infrastructure | $4,293,394 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $3,452,379 |
HKID: Care: Orphans and Vulnerable Children | $3,306,676 |
HVTB: Care: TB/HIV | $1,688,085 |
HMBL: Biomedical Prevention: Blood Safety | $1,040,241 |
PDTX: Treatment: Pediatric Treatment | $356,794 |
PDCS: Care: Pediatric Care and Support | $260,017 |
HTXD: Treatment: ARV Drugs | $23,477 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
Top Partner Programs
Not Available:
$75,286,937
Countries/Regions
USG Aggregated Agencies:
$16,132,489
Countries/Regions
FHI 360:
$16,042,311
Countries/Regions
Voluntary Health Services:
$5,260,000
Countries/Regions
University of Washington:
$4,450,000
Countries/Regions